Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 11:17 (1640 d 22:17 ago) – Posting: # 20128
Views: 2,896

❝ ❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


❝ What does your protocol say on exactly that matter?


My protocol says within (-0.20 and 0.20)

Complete thread:

UA Flag
Activity
 Admin contact
22,763 posts in 4,775 threads, 1,628 registered users;
13 visitors (0 registered, 13 guests [including 2 identified bots]).
Forum time: 09:35 CEST (Europe/Vienna)

The object of statistics is information.
The objective of statistics is the understanding of information
contained in data.    Irwin and Marylees Miller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5